PDS Biotechnology Corporation (NASDAQ: PDSB) started the day on February 22, 2021, with a price increase of 8.12% at $5.46. During the day, the stock rose to $6.20 and sunk to $5.00 before settling in for the price of $5.05 at the close. Taking a more long-term approach, PDSB posted a 52-week range of $0.62-$7.30.
Meanwhile, its Annual Earning per share during the time was 32.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 94.50%. This publicly-traded company’s shares outstanding now amounts to $18.96 million, simultaneously with a float of $16.12 million. The organization now has a market capitalization sitting at $116.79 million. At the time of writing, stock’s 50-day Moving Average stood at $3.17, while the 200-day Moving Average is $2.46.
PDS Biotechnology Corporation (PDSB) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. PDS Biotechnology Corporation’s current insider ownership accounts for 27.61%, in contrast to 16.00% institutional ownership.
PDS Biotechnology Corporation (PDSB) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 9/29/2020, the organization reported -$0.23 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.14) by -$0.09. This company achieved a return on equity of -33.70. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
PDS Biotechnology Corporation’s EPS increase for this current 12-month fiscal period is 94.50% and is forecasted to reach -0.89 in the upcoming year.
PDS Biotechnology Corporation (NASDAQ: PDSB) Trading Performance Indicators
Let’s observe the current performance indicators for PDS Biotechnology Corporation (PDSB). It’s Quick Ratio in the last reported quarter now stands at 11.70. The Stock has managed to achieve an average true range (ATR) of 0.70.
In the same vein, PDSB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.57, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -0.89 at the market close of one year from today.
Technical Analysis of PDS Biotechnology Corporation (PDSB)
If we take a close look at the recent performances of PDS Biotechnology Corporation (NASDAQ: PDSB), its last 5-days Average volume was 1.17 million that shows plunge from its year to date volume of 1.19 million. During the previous 9 days, stock’s Stochastic %D was recorded 34.97% While, its Average True Range was 0.81.
Raw Stochastic average of PDS Biotechnology Corporation (PDSB) in the period of the previous 100 days is set at 66.15%, which indicates a major rise in contrast to 54.50% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 217.83% that was higher than 130.12% volatility it exhibited in the past 100-days period.